Global Sepsis Diagnostics Market, By Technology (Microbiology, Blood Culture, Molecular Diagnostics, Immunoassays, Flow Cytometry, Biomarkers, Microfluidics), Product (Instruments, Blood Culture Media, Assay Kits and Reagents, Software), Method (Conventional Diagnostics, Automated Diagnostics), Pathogen (Bacterial Sepsis, Viral Sepsis, Fungal Sepsis, Others),Test Type (Laboratory Test, Point-Of-Care Test), End User (Hospital, Pathology and Reference Laboratories, Research Laboratories and Academic Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
The sepsis diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 1,050.25 million by 2028 and will grow at a CAGR of 9.50% in the above mentioned forecast period.
Sepsis is a kind of life-threatening organ dysfunction which arises when the body's response to an infection injures its own organs and tissues. It can be caused due to chronic illness, weakened immune system, kidney or liver disease, cancer and severe wounds.
The high incidence of sepsis is amongst the significant factors expected to fuel the growth and demand of sepsis diagnostics market. In addition, the rapid rise in incidence of hospital-acquired infections and increase in funding for sepsis-related research are also anticipated to push the growth in the global sepsis diagnostics market over the forecast period of 2021 to 2028. Likewise, the introduction of technologically advanced diagnostic solutions and increase in awareness are also projected to lift the growth of the market. Furthermore, the high prevalence of different antibiotic resistant bacterial strains and rise in aging population are also expected to act as significant factors which will flourish the growth of the sepsis diagnostics market.
The development of rapid diagnostic/POC techniques for early sepsis diagnosis and the evolution of novel biomarkers for sepsis diagnosis are expected to offer significant growth opportunities for the sepsis diagnostics market in the forecast period of 2021 to 2028.
However, the unfavorable reimbursement scenario as well as the high cost of automated diagnostic devices are estimated to limit the growth of the sepsis diagnostics market, whereas, the lack of standard protocols and awareness and shortage of skilled healthcare professionals can challenge the growth of the sepsis diagnostics market.
This sepsis diagnostics market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players. This report also analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches; as well as dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on sepsis diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Sepsis Diagnostics Market Scope and Market Size
The sepsis diagnostics market is segmented on the basis of technology, product, method, pathogen, test type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on technology, the sepsis diagnostics market is segmented into microbiology, blood culture, molecular diagnostics, immunoassays, flow cytometry, biomarkers and microfluidics. Molecular diagnostics have further been segmented into polymerase chain reaction, microarrays, peptide nucleic acid-fluorescent in situ hybridization and syndromic panel-based testing.
- On the basis of product, the sepsis diagnostics market is segmented into instruments, blood culture media, assay kits and reagents and software.
- The sepsis diagnostics market is segmented on the basis of method into conventional diagnostics and automated diagnostics.
- The pathogen segment of the sepsis diagnostics market is segmented into bacterial sepsis, viral sepsis, fungal sepsis and others. Bacterial sepsis has further been segmented into gram-negative bacterial sepsis and gram-positive bacterial sepsis.
- Based on test type, the sepsis diagnostics market is segmented into laboratory test and point-of-care test.
- Based on end user, the sepsis diagnostics market is segmented into hospital, pathology and reference laboratories and research laboratories and academic institutes.
Sepsis Diagnostics Market Country Level Analysis
The sepsis diagnostics market is analyzed and market size insights and trends are provided by country, technology, product, method, pathogen, test type and end user as referenced above.
The countries covered in the sepsis diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
North America region leads the sepsis diagnostics market owing to the presence of well-established healthcare infrastructure as well as the high adoption of advanced diagnostic solutions. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 because of the increase in the demand for sepsis diagnostic solutions and high prevalence of infectious diseases.
The country section of the sepsis diagnostics market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The sepsis diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for sepsis diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the sepsis diagnostics market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Sepsis Diagnostics Market Share Analysis
The sepsis diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to sepsis diagnostics market.
The major players covered in the sepsis diagnostics market report are bioMérieux SA, BD, Danaher, T2 Biosystems, Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., Bruker, Abbott, Immunexpress Inc., RESPONSE BIOMEDICAL, Axis-Shield Diagnostics Ltd., CYTOSORBENTS EUROPE GMBH,EKF Diagnostics Holdings plc, Seegene Inc., GenMark Diagnostics, Inc., BODITECH MED INC., Alpha Laboratories Ltd., Alifax S.r.l., and Koninklijke Philips N.V., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Sepsis Diagnostics Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.